Compositions and methods for treating HCV
US10201584B1 · kind B1 · utility
0Cited by
110References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2014 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Apr 8, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure is directed to pharmaceutical compositions that comprise two or more therapeutic agents that, inter alia, are useful for inhibiting hepatitis C virus (HCV) and methods for inhibiting HCV by co-administering two or more anti-HCV therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.